Indeterminate leprosy: a therapeutic evaluation.
Out of 50 cases of indeterminate leprosy, 46 were male and 4 were female. The only clinical finding was a single hypopigmented macule in 38 (76%) cases. Nine (18%) patients had two and three (6%) cases had three hypopigmented macules. All patients were treated with multidrug therapy for one year. At the end of six months, the lesions were still active in 12 (24%) cases. At the end of one year of treatment it was found that 33 (66%) patients became inactive and 3 (6%) cases were still to be active. The study shows that all indeterminate leprosy cases must be treated with multidrug therapy till all signs of activity are subsided.
Kar
P K
PK
Command Hospital (SC) Pune.
Jha
P K
PK
Snehi
P S
PS
D000293:Adolescent; D000328:Adult; D002648:Child; D003622:Dapsone / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007918:Leprosy / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D012880:Skin Pigmentation
D003622:Dapsone; D012293:Rifampin